跳至主要内容
临床试验/NCT04226742
NCT04226742已完成不适用

Evaluation of the Crowd-Powered Web Platform for Accumulative Depression and Anxiety Plans and Treatment (ADAPT)

University of California, Irvine2 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2021年2月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
107
试验地点
2
主要终点
Anxiety Scores at 16 Weeks

研究概览

简要总结

100 participants will be enrolled in a two-armed randomized controlled trial of the Accumulated Depression and Anxiety Plans and Treatments (ADAPT) platform which integrates internet Cognitive Behavioral Therapy (iCBT) to determine impact on symptoms of depression and anxiety. This trial will pilot the effectiveness of the ADAPT platform, and evaluate the extent to which the ADAPT platform engages putative targets of personal relevance, skills use, and skills mastery.

详细描述

The investigators will enroll 100 participants in a two-armed randomized controlled trial of the ADAPT platform (iCBT). Participants will be randomly assigned to receive either the ADAPT platform (treatment) or a similar self-guided platform (control) that contains the didactic material (learning) but lacks the ADAPT platforms "crowd" features. Participants will use their assigned platform for a treatment period of 8 weeks. Participants will receive trial assessments at baseline, week 4, and week 8 (post-treatment). Follow-up evaluations will occur at 16 weeks to evaluate maintenance of gains. This pilot effectiveness trial aims to determine the impact on symptoms of depression and anxiety and whether the platform engages the putative targets of personal relevance, relationship, resulting in increased skills mastery and skills use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Participants will be unaware of which condition they have been assigned.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Completion of the Mental Health America Screening to Supports (MHA S2S) or significant mood and anxiety symptoms as defined by an accepted cut-off on a validated measure the Depression Anxiety and Stress Scale (DASS). The accepted cut-off is scores greater than 22;
  • able to speak and read English;
  • at least 18 years of age.

排除标准

  • severe suicidality (has ideation, plan, and intent)

结局指标

主要结局

Anxiety Scores at 16 Weeks

时间窗: Absolute scores at Week 16

The primary outcome of symptoms of anxiety will be measured with the self-report anxiety subscale of the Depression Anxiety Stress Scale (DASS). The subscale for anxiety ranges from 7 to 28 with lower values (lowest value = 7) indicating lower levels of anxiety and higher values (highest value = 28) indicating higher levels of anxiety.

Depression Scores at Week 16

时间窗: Absolute scores at Week 16

The primary outcome of symptoms of depression will be measured with the self-report depression subscale of the Depression Anxiety Stress Scale (DASS). The subscale for depression ranges from 7 to 28 with lower values (lowest value = 7) indicating lower levels of depression and higher values (highest value = 28) indicating higher levels of depression.

次要结局

  • Cognitive and Behavioral Skills Scores at 16 Weeks(Absolute scores at Week 16)
  • Accountability Scores at 16 Weeks(Absolute scores at Week 16)
  • Self-efficacy Scores at 16 Weeks(Absolute scores at Week 16)
  • Social Functioning Scores at 16 Weeks(Absolute scores at Week 16)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen Matthew Schueller

Assistant Proffessor

University of California, Irvine

研究点 (2)

Loading locations...

相似试验